Metcalfe David A's Form 4 filing
Nextgen Healthcare, Inc. (NXGN) · filed Oct 28, 2022
- Accession no.
- 0001209191-22-054850
- Filed
- Oct 28, 2022
- Trade date
- Oct 26-27, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $654.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Metcalfe David ACIK 0001664295 | Officer (Chief Technology Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 | Common Stock | MOption exerciseAcquired | +32,372 | $14.20 | +$459,682.4 | 181,148 | Direct | |
| Oct 26, 2022 | Common Stock | SSaleDisposed | −32,372 | $20.21F2 | −$654,238.12 | 148,776 | Direct | |
| Oct 27, 2022 | Common Stock | FTax withholdingDisposed | −6,091 | $19.02 | −$115,850.82 | 142,685 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2022 | Common Stock | MOption exerciseDisposed | −32,372 | $0.00 | $0 | 117,628 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.415. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
Referenced by the price of 1 transaction in Table I.